2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Cancer of Esophagus

2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with Cancer of Esophagus in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Ethirajan, M; Joshi, P; Pandey, RK	1
Allamaneni, SS; Cooper, MT; Dougherty, TJ; Henderson, BW; Nava, HR; Tan, W; Wilding, G	1
Bellnier, DA; Dougherty, TJ; Greco, WR; Loewen, GM; Nava, H; Oseroff, AR; Pandey, RK; Tsuchida, T	1

Reviews

1 review(s) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Cancer of Esophagus

Article	Year
The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chemical Society reviews, 2011, Volume: 40, Issue:1 Topics: Animals; Chlorophyll; Esophageal Neoplasms; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins	2011

Trials

1 trial(s) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Cancer of Esophagus

Article	Year
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus. Lasers in surgery and medicine, 2011, Volume: 43, Issue:7 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Barrett Esophagus; Chlorophyll; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Esophageal Neoplasms; Esophagoscopy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Treatment Outcome	2011

Article

Year

Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.

Lasers in surgery and medicine, 2011, Volume: 43, Issue:7

Topics: Adenocarcinoma; Aged; Aged, 80 and over; Barrett Esophagus; Chlorophyll; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Esophageal Neoplasms; Esophagoscopy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Treatment Outcome

2011

Other Studies

1 other study(ies) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and Cancer of Esophagus

Article	Year
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer research, 2003, Apr-15, Volume: 63, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Blood Proteins; Carcinoma, Basal Cell; Chlorophyll; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Esophageal Neoplasms; Humans; Lung Neoplasms; Middle Aged; Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms	2003

Article

Year

Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.

Cancer research, 2003, Apr-15, Volume: 63, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Blood Proteins; Carcinoma, Basal Cell; Chlorophyll; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Esophageal Neoplasms; Humans; Lung Neoplasms; Middle Aged; Neoplasms; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms

2003